The EC approved upadacitinib for active polyarticular JIA in children 2 years and older, based on phase 1 SELECT-YOUTH efficacy and safety data.
|Articles|July 24, 2013
45-Year-Old Woman With Longstanding Knee Pain
Images taken 7 months apart show subtle densities of the left knee that has been causing pain. The woman also has subluxation of the fingers, without erosion.
Advertisement
These images, taken 7 months apart, show the left knee that has been causing a 45-year-old woman to endure substantial pain for a very long time.
The one at left shows subtle densities that are more conspicuous on the later image, at right, with a serpiginous, well defined, sclerotic border.
Hand radiographs show ulnar subluxation of the metacarpophalaneal joints, without erosion.
What would you look for on MRI? What diagnosis would you predict?
Click here to read the
Advertisement
Related to this article
August 2026 rheumatology highlights include FDA approval of brepocitinib for dermatomyositis and garetosmab-grts for FOP, and new trial data.
In RA-BRIDGE and RA-BRANCH, baricitinib failed to demonstrate VTE noninferiority in patients with RA enriched for thromboembolic risk factors.
A Phase 2a basket trial produced ACR50 responses in 71% of refractory RA patients at 6 months.
Advertisement
Advertisement